Please ensure Javascript is enabled for purposes of website accessibility
Home / News / St. Charles Business Record / KV, Purdue Pharma settle OxyContin patent lawsuit

KV, Purdue Pharma settle OxyContin patent lawsuit

KV Pharmaceutical Co., a drugmaker whose shares have dropped 92 percent in the past year, said it settled a patent lawsuit with Purdue Pharma LP over the OxyContin painkiller. Under the agreement, KV acknowledges the validity and enforceability of Purdue's OxyContin patents, the St. Louis-based company said Wednesday in a statement distributed by PR Newswire. In ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*